Hormone drug may boost healing of cesarean scar defects

NCT ID NCT05206682

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares vaginal repair surgery alone versus surgery followed by leuprorelin, a drug that temporarily stops menstruation. The goal is to see if delaying periods helps the scar defect heal better. The trial includes 94 women with cesarean scar defects and adenomyosis who have prolonged bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Leuprorelin

What this could lead to

If it works, this could point toward a better way to treat cesarean scar defects and reduce prolonged menstrual bleeding.

What could go wrong

This is a small, early-stage trial with only 94 participants. The drug may not improve healing, and side effects from leuprorelin are possible.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOMYOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai Jiaotong University xinhua hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200092, China

    Contact Phone: •••-•••-••••